Classification Nuance. The OpenFDA dataset, which draws from the Structured Product Labeling (SPL) files, often includes multiple classification fields, and the specific string "Phosphate Binder [EPC]" may only be assigned to a single product. The other drugs are likely classified using: More Specific Classes: Many of those drugs (like sevelamer, ferric citrate, etc.) may be classified by their specific mechanism or chemical group, which also acts as a phosphate binder. Example: A drug might be classified as "Iron-Containing Compound [EPC]" or "Aluminum-Containing Compound [EPC]" instead of the more general "Phosphate Binder [EPC]". Different Classification Fields: The NDC data contains several classification fields. You might be checking the Established Pharmacological Class (pharm_class_epc), but the other drugs might be listed under: Mechanism of Action (pharm_class_moa), Physiological Effect (pharm_class_pe)
  Home  

Enter a class name or drug name above to search the database.

HER2/neu Receptor Antagonist [EPC]

NDC Number Brand Name Generic Name Manufacturer Dosage Form DEA Sch. Marketing Start Date
0069-0305 Trazimera trastuzumab-qyyp Pfizer Laboratories Div Pfizer Inc KIT 2020-02-24
0069-0308 Trazimera trastuzumab-qyyp Pfizer Laboratories Div Pfizer Inc INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION 2021-03-10
50242-077 Herceptin Hylecta Trastuzumab and hyaluronidase-oysk Genentech, Inc. INJECTION, SOLUTION 2019-02-28
50242-132 Herceptin Trastuzumab Genentech, Inc. INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION 2017-02-10
50242-145 PERJETA Pertuzumab Genentech, Inc. INJECTION, SOLUTION, CONCENTRATE 2012-06-08
50242-245 Phesgo pertuzumab, trastuzumab, and hyaluronidase-zzxf Genentech, Inc. INJECTION, SOLUTION 2020-06-29
50242-260 Phesgo pertuzumab, trastuzumab, and hyaluronidase-zzxf Genentech, Inc. INJECTION, SOLUTION 2020-06-29
55513-132 Kanjinti trastuzumab-anns Amgen, Inc INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION 2019-06-11
55513-141 Kanjinti trastuzumab-anns Amgen, Inc INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION 2019-10-28
63459-303 HERZUMA TRASTUZUMAB Cephalon, Inc. INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION 2020-03-16
63459-305 HERZUMA TRASTUZUMAB Cephalon, Inc. KIT 2020-03-16
69448-015 HERCESSI trastuzumab-strf Accord BioPharma Inc. INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION 2025-01-01
69448-016 HERCESSI trastuzumab-strf Accord BioPharma Inc. INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION 2025-01-01
70720-022 MARGENZA margetuximab-cmkb TerSera Therapeutics LLC INJECTION, SOLUTION, CONCENTRATE 2021-01-15
74527-022 MARGENZA margetuximab-cmkb MacroGenics, Inc INJECTION, SOLUTION, CONCENTRATE 2021-01-15
78206-147 Ontruzant trastuzumab Organon LLC INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION 2021-06-01
78206-148 Ontruzant Ontruzant Organon LLC KIT 2021-06-01
83257-001 OGIVRI trastuzumab-dkst Biocon Biologics Inc. INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION 2023-10-01
83257-003 OGIVRI trastuzumab-dkst Biocon Biologics Inc. INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION 2023-10-01
83257-004 OGIVRI trastuzumab-dkst Biocon Biologics Inc. KIT 2023-10-01



 [EPC] Established Pharmacological Classification 

Loading full table content...